Hospital systems, payers, pharma, and life sciences operators run inside the most heavily regulated software estate Microsoft sells into. HIPAA, HITECH, FDA Part 11, GxP, EHR uptime, and PHI handling are not optional features. They are obligations. We negotiate the contract that reflects what your regulator and clinical risk officer actually require, not the one Microsoft prefers to write. $420M+ recovered. 340+ engagements. Buyer side only.
Healthcare buyers face a stack of clinical, regulatory, and patient safety constraints that Microsoft prices against. Most of those constraints are non negotiable, which the deal desk knows. Our job is to translate clinical and regulatory language into commercial leverage.
Healthcare operators must demonstrate PHI encryption, immutable audit logs, validated environments for clinical systems, and breach notification readiness. Microsoft prices the regulated tier knowing the alternative is an examiner finding. The cost is paying premium for what regulators demand while still leaving real exposure on the table.
Microsoft 365 E5 with Compliance and Security add ons across clinical and corporate staff. Defender for Cloud across hybrid hospital estate. Sentinel ingesting EHR adjacent infrastructure. Azure with reserved instances supporting imaging, research, and analytics. Power BI for population health and quality reporting. Dynamics for care coordination and patient engagement.
Healthcare specific terms, HIPAA addenda, expanded BAA scope, FDA validation support, and PHI exit assistance language exist. They are gated behind escalation paths buyer side procurement is rarely shown.
We map every clinical and regulatory requirement to a concession we can extract. Bundles you do not need are unwound. HIPAA addenda are bargained, not gifted. Audit posture closes inside the renewal cycle.
Healthcare consolidation is constant. The agreements we structure handle hospital affiliations, divested service lines, and acquired practices without surprise true up exposure or compliance gaps.
We advise across the healthcare map. Top tier integrated delivery networks on EA renewal. Regional hospitals on M365 right sizing for clinical workforces. Payers on Defender and Sentinel ingestion economics. Pharma operators on FDA validated cloud commits. Medical device firms on Azure IoT and connected product licensing. Same playbook, scaled to the contract.
The pattern that fails: a procurement led negotiation that wins price but loses on terms that examiners, auditors, or operators later flag. The pattern that works: a posture led negotiation where pricing falls out of the work, not the other way around.
Microsoft quotes the healthcare tier knowing that compliance officers, clinical risk leaders, and internal audit functions create structural reluctance to push back. The fear is that negotiating somehow weakens patient safety posture or regulator standing. The opposite is true. A defensible contract is a documented one. Regulators reward demonstrated diligence over premium spend on tooling that clinicians never log into.
The most common pattern we see in healthcare Microsoft estates: E5 across the entire workforce when only 41 percent require the compliance tier, Defender stacks paid twice through M365 and Azure, Sentinel ingestion costs nobody modeled before the SOC turned it on, and Azure commits sized to a digital transformation roadmap the board quietly slowed two cycles ago.
We do not resell Microsoft. We do not partner with Microsoft. We do not earn referral fees from any reseller or LSP. We do not opine on whether a given control satisfies HIPAA or FDA expectations. That is the work of internal compliance, privacy counsel, and quality assurance. We negotiate the commercial instrument that surrounds those controls.
We also do not run pure benchmarking projects in isolation. Concession data is necessary but never sufficient. Every healthcare engagement is grounded in actual consumption, actual entitlement, actual clinician seat counts, and the actual posture clinical and regulatory leadership expects. The contract follows the truth, not the catalog.
Anonymized but verifiable on reference call. Drawn from active engagements in the trailing twelve months across the practice.
The opening quote bundled M365 E5 across every clinical and corporate seat, a Defender stack the system already owned through Azure, and a MACC sized to an imaging analytics roadmap that had been deferred. We rebuilt the proposal from active clinical login data, regulatory letters, and the actual digital strategy. Audit posture closed inside the renewal.
They turned our HIPAA and clinical risk language directly into commercial leverage. Microsoft never pushed back on the right size because the data behind it was theirs.Chief Information Officer · 24 hospital IDN
Every engagement produces written deliverables your CIO, CFO, audit committee, and board can read directly. Nothing lives only in our heads.
Board ready narrative of where the contract sits, what leverage exists, and what the disciplined ask is. Signed off jointly with internal stakeholders.
Concession data from signed contracts in your sector, your spend tier, and your renewal quarter. Sourced from active practice engagements.
Calendar of milestones, internal alignment checkpoints, Microsoft engagement touch points, and decision dates from posture through signature.
Live tracker of every ask, every counter, every Microsoft concession landed, and every term we have not yet closed. Updated through signature.
Two analyst calls. No pitch. We tell you what we would do, what the leverage actually is for a healthcare buyer, and whether we are the right firm for this engagement.